The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Peritoneal Dialysis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Peritoneal Dialysis


Psychiatry related information on Peritoneal Dialysis


High impact information on Peritoneal Dialysis


Chemical compound and disease context of Peritoneal Dialysis


Biological context of Peritoneal Dialysis


Anatomical context of Peritoneal Dialysis


Associations of Peritoneal Dialysis with chemical compounds


Gene context of Peritoneal Dialysis


Analytical, diagnostic and therapeutic context of Peritoneal Dialysis


  1. Increased lipoprotein-remnant formation in chronic renal failure. Nestel, P.J., Fidge, N.H., Tan, M.H. N. Engl. J. Med. (1982) [Pubmed]
  2. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. Salusky, I.B., Foley, J., Nelson, P., Goodman, W.G. N. Engl. J. Med. (1991) [Pubmed]
  3. Segmental chloride and fluid handling during correction of chloride-depletion alkalosis without volume expansion in the rat. Galla, J.H., Bonduris, D.N., Dumbauld, S.L., Luke, R.G. J. Clin. Invest. (1984) [Pubmed]
  4. Acute oliguric renal failure induced by indomethacin: possible mechanism. Walshe, J.J., Venuto, R.C. Ann. Intern. Med. (1979) [Pubmed]
  5. High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Jones, R.B., Collins, J.M., Myers, C.E., Brooks, A.E., Hubbard, S.M., Balow, J.E., Brennan, M.F., Dedrick, R.L., DeVita, V.T. Cancer Res. (1981) [Pubmed]
  6. Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response. Toorians, A.W., Janssen, E., Laan, E., Gooren, L.J., Giltay, E.J., Oe, P.L., Donker, A.J., Everaerd, W. Nephrol. Dial. Transplant. (1997) [Pubmed]
  7. Erectile dysfunction in chronic peritoneal dialysis patients: incidence and treatment with sildenafil. Juergense, P.H., Botev, R., Wuerth, D., Finkelstein, S.H., Smith, J.D., Finkelstein, F.O. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. (2001) [Pubmed]
  8. Gabapentin in treatment of restless legs syndrome in peritoneal dialysis patients. Tan, J., Derwa, A., Sanu, V., Rahman, N., Woodrow, G. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. (2006) [Pubmed]
  9. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. Bergstein, J.M., Riley, M., Bang, N.U. N. Engl. J. Med. (1992) [Pubmed]
  10. Arthritis associated with calcium oxalate crystals in an anephric patient treated with peritoneal dialysis. Rosenthal, A., Ryan, L.M., McCarty, D.J. JAMA (1988) [Pubmed]
  11. Hazards of overconcentrated milk formula. Hyperosmolality, disseminated intravascular coagulation and gangrene. Abrams, C.A., Phillips, L.L., Berkowitz, C., Blackett, P.R., Priebe, C.J. JAMA (1975) [Pubmed]
  12. Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. Friedlander, M.A., Wu, Y.C., Elgawish, A., Monnier, V.M. J. Clin. Invest. (1996) [Pubmed]
  13. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. Tjiong, H.L., van den Berg, J.W., Wattimena, J.L., Rietveld, T., van Dijk, L.J., van der Wiel, A.M., van Egmond, A.M., Fieren, M.W., Swart, R. J. Am. Soc. Nephrol. (2005) [Pubmed]
  14. Fluconazole treatment without catheter removal in Candida albicans peritonitis complicating peritoneal dialysis. Corbella, X., Sirvent, J.M., Carratalá, J. Am. J. Med. (1991) [Pubmed]
  15. Long-term intraperitoneal deferoxamine for hemochromatosis. Swartz, R.D., Legault, D.J. Am. J. Med. (1996) [Pubmed]
  16. Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Rodby, R.A., Korbet, S.M., Lewis, E.J. Am. J. Med. (1987) [Pubmed]
  17. Nephrotoxicity associated with cephalothin administration. Carling, P.C., Idelson, B.A., Casano, A.A., Alexander, E.A., McCabe, W.R. Arch. Intern. Med. (1975) [Pubmed]
  18. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis. Manley, H.J., Bailie, G.R., Frye, R., Hess, L.D., McGoldrick, M.D. J. Am. Soc. Nephrol. (2000) [Pubmed]
  19. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. Wynne, K., Giannitsopoulou, K., Small, C.J., Patterson, M., Frost, G., Ghatei, M.A., Brown, E.A., Bloom, S.R., Choi, P. J. Am. Soc. Nephrol. (2005) [Pubmed]
  20. Ketoconazole kinetics in chronic peritoneal dialysis. Johnson, R.J., Blair, A.D., Ahmad, S. Clin. Pharmacol. Ther. (1985) [Pubmed]
  21. Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Szeto, C.C., Chow, K.M., Poon, P., Szeto, C.Y., Wong, T.Y., Li, P.K. Kidney Int. (2004) [Pubmed]
  22. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Margetts, P.J., Kolb, M., Yu, L., Hoff, C.M., Holmes, C.J., Anthony, D.C., Gauldie, J. Am. J. Pathol. (2002) [Pubmed]
  23. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. Bonomini, M., Sirolli, V., Settefrati, N., Dottori, S., Di Liberato, L., Arduini, A. J. Am. Soc. Nephrol. (1999) [Pubmed]
  24. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. Ito, T., Yorioka, N., Yamamoto, M., Kataoka, K., Yamakido, M. J. Am. Soc. Nephrol. (2000) [Pubmed]
  25. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. Heimbürger, O., Lönnqvist, F., Danielsson, A., Nordenström, J., Stenvinkel, P. J. Am. Soc. Nephrol. (1997) [Pubmed]
  26. 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Catalan, M.P., Santamaría, B., Reyero, A., Ortiz, A., Egido, J., Ortiz, A. Kidney Int. (2005) [Pubmed]
  27. Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure. Goldsmith, D., Jayawardene, S., Sabharwal, N., Cooney, K. Lancet (2000) [Pubmed]
  28. Serum aluminium levels in patients on peritoneal dialysis. Gilli, P., Farinelli, A., Fagioli, F., De Bastiani, P., Buoncristiani, U. Lancet (1980) [Pubmed]
  29. Ototoxicity of erythromycin in peritoneal dialysis patients. Taylor, R., Schofield, I.S., Ramos, J.M., Bint, A.J., Ward, M.K. Lancet (1981) [Pubmed]
  30. Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Low, D.E., Vas, S.I., Oreopoulos, D.G., Manuel, M.A., Saiphoo, M.M., Finer, C., Dombros, N. Lancet (1980) [Pubmed]
  31. Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis. Cattran, D.C., Fenton, S.S., Wilson, D.R., Steiner, G. Ann. Intern. Med. (1976) [Pubmed]
  32. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Mandl-Weber, S., Cohen, C.D., Haslinger, B., Kretzler, M., Sitter, T. Kidney Int. (2002) [Pubmed]
  33. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Hausmann, M.J., Rogachev, B., Weiler, M., Chaimovitz, C., Douvdevani, A. Kidney Int. (2000) [Pubmed]
  34. Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients. Zarrinkalam, K.H., Stanley, J.M., Gray, J., Oliver, N., Faull, R.J. Kidney Int. (2003) [Pubmed]
  35. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Proulx, F., Toledano, B., Phan, V., Clermont, M.J., Mariscalco, M.M., Seidman, E.G. Pediatr. Res. (2002) [Pubmed]
  36. Erythropoietin and sexual dysfunction. Lawrence, I.G., Price, D.E., Howlett, T.A., Harris, K.P., Feehally, J., Walls, J. Nephrol. Dial. Transplant. (1997) [Pubmed]
  37. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Mistry, C.D., Mallick, N.P., Gokal, R. Lancet (1987) [Pubmed]
  38. Survival after massive (>2000) Africanized honeybee stings. Díaz-Sánchez, C.L., Lifshitz-Guinzberg, A., Ignacio-Ibarra, G., Halabe-Cherem, J., Quinones-Galvan, A. Arch. Intern. Med. (1998) [Pubmed]
  39. Extracorporeal treatment of salicylate or acetaminophen poisoning--is there a role? Winchester, J.F., Gelfand, M.C., Helliwell, M., Vale, J.A., Goulding, R., Schreiner, G.E. Arch. Intern. Med. (1981) [Pubmed]
  40. Total parenteral nutrition therapy of toxic maple syrup urine disease. Townsend, I., Kerr, D.S. Am. J. Clin. Nutr. (1982) [Pubmed]
  41. Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamine. Hercz, G., Salusky, I.B., Norris, K.C., Fine, R.N., Coburn, J.W. Kidney Int. (1986) [Pubmed]
WikiGenes - Universities